Caregivers Should Be Mindful of Gabapentin’s Interactions with Other Medications
For those suffering from symptoms of familial amyloid polyneuropathy — such as loss of nerve function in the hands, feet, arms, and legs — ... Read more
Updates
-
-
Risk of FAP Prompts Most Pre-symptomatic Neurological Testing, Portuguese Study Says
Persons at risk for familial amyloid polyneuropathy (FAP) represent the vast majority of those who undergo pre-symptomatic testing for late-onset neurological diseases (LONDs) in ... Read more -
Caregivers Should Be Aware of Gabapentin’s Side Effects
For caregivers tasked with the care of a loved one suffering from familial amyloid polyneuropathy, understanding the symptoms of the disease and its prescribed ... Read more -
Long-term Efficacy of Vyndaqel in FAP Patients with Val30Met Mutations Supported in Study
Therapy with Vyndaqel (tafamidis) nearly stops or slows the progression of familial amyloid polyneuropathy (FAP) in most patients with Val30Met mutations at the transthyretin ... Read more -
World’s First Alport Stamp Is Macedonian Mom’s Latest Win for Rare Disease Patients
It wasn’t until Gordana Loleska’s son David was 14 years old that doctors in their native North Macedonia diagnosed his kidney, vision, and hearing ... Read more
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
-
Blood Biomarkers Show Inflammation in FAP Patients Before Amyloid Deposits Evident, Study Find
Changes in the immune system and in inflammation may occur before the formation and ... -
Diet and Nutrition Help Relieve Peripheral Neuropathy Symptoms
Familial amyloid polyneuropathy comes with plenty of symptoms that patients and caregivers must be ... -
NORD Honors Industry, Patient Advocates at Rare Impact Awards Gala
A violinist with vasculitis, two Texas politicians and a pharmaceutical company whose marijuana-derived therapy ... -
Traveling with Nerve Pain Symptoms
The peripheral symptoms of familial amyloid polyneuropathy (FAP) may prove troublesome for the maneuverability ... -
Eurordis Unveils Integrated-care Initiative for Rare Disease Patients
Europe’s umbrella organization for 800 rare disease associations has developed a sweeping initiative to ...
Tafamidis Delays Disease Progression in Patients with Transthyretin Amyloid Polyneuropathy, Pfizer Study Suggests
News
An interim analysis of the Phase 3 trial for tafamidis (Fx-1006A) as a therapy for patients with hereditary transthyretin amyloid polyneuropathy (TTR-FAP) shows the investigational treatment delays disease progression, Pfizer announced. The study, “Long-term safety and efficacy of tafamidis for ... Read more